Ameriprise’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $119M | Sell |
2,161,172
-2,046,391
| -49% | -$112M | 0.03% | 495 |
|
2025
Q1 | $297M | Sell |
4,207,563
-292,685
| -7% | -$20.7M | 0.08% | 250 |
|
2024
Q4 | $296M | Buy |
4,500,248
+218,766
| +5% | +$14.4M | 0.08% | 256 |
|
2024
Q3 | $301M | Sell |
4,281,482
-419,844
| -9% | -$29.5M | 0.08% | 267 |
|
2024
Q2 | $387M | Sell |
4,701,326
-702,219
| -13% | -$57.8M | 0.1% | 204 |
|
2024
Q1 | $472M | Sell |
5,403,545
-15,821
| -0.3% | -$1.38M | 0.13% | 171 |
|
2023
Q4 | $523M | Buy |
5,419,366
+255,417
| +5% | +$24.6M | 0.16% | 145 |
|
2023
Q3 | $457M | Buy |
5,163,949
+275,436
| +6% | +$24.4M | 0.15% | 149 |
|
2023
Q2 | $424M | Sell |
4,888,513
-49,833
| -1% | -$4.32M | 0.13% | 168 |
|
2023
Q1 | $480M | Buy |
4,938,346
+289,718
| +6% | +$28.2M | 0.16% | 147 |
|
2022
Q4 | $481M | Sell |
4,648,628
-1,046,606
| -18% | -$108M | 0.16% | 136 |
|
2022
Q3 | $483M | Sell |
5,695,234
-120,343
| -2% | -$10.2M | 0.18% | 124 |
|
2022
Q2 | $482M | Buy |
5,815,577
+475,127
| +9% | +$39.4M | 0.17% | 127 |
|
2022
Q1 | $412M | Sell |
5,340,450
-1,211,211
| -18% | -$93.4M | 0.12% | 178 |
|
2021
Q4 | $579M | Sell |
6,551,661
-277,515
| -4% | -$24.5M | 0.16% | 131 |
|
2021
Q3 | $528M | Buy |
6,829,176
+278,927
| +4% | +$21.6M | 0.17% | 123 |
|
2021
Q2 | $547M | Buy |
6,550,249
+316,914
| +5% | +$26.4M | 0.17% | 133 |
|
2021
Q1 | $471M | Buy |
6,233,335
+1,873,040
| +43% | +$141M | 0.16% | 137 |
|
2020
Q4 | $382M | Buy |
4,360,295
+1,354,135
| +45% | +$119M | 0.14% | 159 |
|
2020
Q3 | $229M | Sell |
3,006,160
-127,540
| -4% | -$9.7M | 0.09% | 230 |
|
2020
Q2 | $387M | Buy |
3,133,700
+135,564
| +5% | +$16.7M | 0.17% | 132 |
|
2020
Q1 | $253M | Sell |
2,998,136
-198,723
| -6% | -$16.8M | 0.13% | 166 |
|
2019
Q4 | $270M | Buy |
3,196,859
+305,237
| +11% | +$25.8M | 0.11% | 192 |
|
2019
Q3 | $195M | Buy |
2,891,622
+3,229
| +0.1% | +$218K | 0.09% | 238 |
|
2019
Q2 | $247M | Buy |
2,888,393
+235,219
| +9% | +$20.1M | 0.11% | 196 |
|
2019
Q1 | $236M | Sell |
2,653,174
-8,046
| -0.3% | -$714K | 0.11% | 204 |
|
2018
Q4 | $227M | Sell |
2,661,220
-66,384
| -2% | -$5.65M | 0.11% | 195 |
|
2018
Q3 | $266M | Buy |
2,727,604
+293,137
| +12% | +$28.6M | 0.09% | 236 |
|
2018
Q2 | $229M | Buy |
2,434,467
+1,597,750
| +191% | +$150M | 0.1% | 205 |
|
2018
Q1 | $67.8M | Sell |
836,717
-215,427
| -20% | -$17.5M | 0.03% | 515 |
|
2017
Q4 | $93.8M | Buy |
1,052,144
+81,380
| +8% | +$7.26M | 0.04% | 392 |
|
2017
Q3 | $90.3M | Buy |
970,764
+36,227
| +4% | +$3.37M | 0.04% | 393 |
|
2017
Q2 | $84.9M | Sell |
934,537
-671,904
| -42% | -$61M | 0.04% | 400 |
|
2017
Q1 | $141M | Buy |
1,606,441
+31,983
| +2% | +$2.81M | 0.07% | 274 |
|
2016
Q4 | $130M | Buy |
1,574,458
+62,754
| +4% | +$5.2M | 0.07% | 282 |
|
2016
Q3 | $140M | Buy |
1,511,704
+31,959
| +2% | +$2.96M | 0.08% | 252 |
|
2016
Q2 | $115M | Buy |
1,479,745
+168,586
| +13% | +$13.1M | 0.07% | 278 |
|
2016
Q1 | $108M | Buy |
1,311,159
+333,888
| +34% | +$27.5M | 0.06% | 291 |
|
2015
Q4 | $102M | Buy |
977,271
+328,161
| +51% | +$34.4M | 0.06% | 300 |
|
2015
Q3 | $68.4M | Sell |
649,110
-209,076
| -24% | -$22M | 0.04% | 375 |
|
2015
Q2 | $117M | Sell |
858,186
-23,750
| -3% | -$3.25M | 0.07% | 282 |
|
2015
Q1 | $110M | Buy |
881,936
+153,657
| +21% | +$19.2M | 0.06% | 297 |
|
2014
Q4 | $65.8M | Buy |
728,279
+392,060
| +117% | +$35.4M | 0.04% | 432 |
|
2014
Q3 | $24.3M | Sell |
336,219
-229,338
| -41% | -$16.5M | 0.01% | 841 |
|
2014
Q2 | $35.2M | Sell |
565,557
-609,261
| -52% | -$37.9M | 0.02% | 701 |
|
2014
Q1 | $80.1M | Buy |
1,174,818
+261,492
| +29% | +$17.8M | 0.05% | 361 |
|
2013
Q4 | $64.2M | Buy |
913,326
+149,726
| +20% | +$10.5M | 0.04% | 443 |
|
2013
Q3 | $55.1M | Sell |
763,600
-41,359
| -5% | -$2.99M | 0.04% | 494 |
|
2013
Q2 | $44.9M | Buy |
+804,959
| New | +$44.9M | 0.03% | 555 |
|